Irene Eijgendaal

Title: Innovations and Contributions of Irene Eijgendaal

Introduction

Irene Eijgendaal is a notable inventor based in Weesp, Netherlands. She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel dosage forms and compounds. With a total of three patents to her name, her work has had a meaningful impact on the treatment of various diseases and disorders.

Latest Patents

One of her latest patents is titled "Bifeprunox mesylate maintenance dose compositions and methods for using the same." This patent provides novel pharmaceutical dosage forms, including a maintenance treatment dose, and outlines methods for making and using these compounds to treat and prevent diseases. Another significant patent is for a "Stable crystalline form of bifeprunox mesylate." This invention relates to a stable polymorphic form of the compound 7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate. It includes a method for preparing this polymorphic form and its application in pharmaceutical products, especially for treating psychotic disorders and Parkinson's disease.

Career Highlights

Irene has worked with prominent companies in the pharmaceutical industry, including Solvay Pharmaceuticals B.V. and Solvay Pharmaceuticals GmbH. Her experience in these organizations has contributed to her expertise in drug development and innovation.

Collaborations

Irene has collaborated with notable colleagues such as Gerrit Klein and Maria J. L. Terhorst-Van Amstel. These collaborations have likely enriched her research and development efforts in the pharmaceutical field.

Conclusion

Irene Eijgendaal's contributions to pharmaceutical innovations through her patents and collaborations highlight her role as a significant inventor in her field. Her work continues to influence the development of treatments for various medical conditions.